Cargando…
Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome
Down syndrome (DS) is a complex genetic disorder associated with substantial physical, cognitive, and behavioral challenges. Due to better treatment options for the physical co-morbidities of DS, the life expectancy of individuals with DS is beginning to approach that of the general population. Howe...
Autores principales: | Stensen, Wenche, Rothweiler, Ulli, Engh, Richard Alan, Stasko, Melissa R., Bederman, Ilya, Costa, Alberto C. S., Fugelli, Anders, Svendsen, John S. Mjøen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617627/ https://www.ncbi.nlm.nih.gov/pubmed/34832952 http://dx.doi.org/10.3390/ph14111170 |
Ejemplares similares
-
DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer’s Disease-Down Syndrome Phenotypes
por: Zhu, Bangfu, et al.
Publicado: (2022) -
Anti-Colonization Effect of Au Surfaces with Self-Assembled Molecular Monolayers Functionalized with Antimicrobial Peptides on S. epidermidis
por: Karlsen, Eskil André, et al.
Publicado: (2021) -
DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity
por: Zhu, Bangfu, et al.
Publicado: (2022) -
DYRK1A Kinase Inhibitors Promote β-Cell Survival and Insulin Homeostasis
por: Barzowska, Agata, et al.
Publicado: (2021) -
Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits
por: Stringer, Megan, et al.
Publicado: (2017)